|
US 7,320,996 B2 |
|
Indolinone protein kinase inhibitors and cyclooxygenase inhibitors for use in combination therapy for the treatment of cancer |
Jaime Masferrer, Ballwin, Mo. (US); Parul Doshi, Wildwood, Mo. (US); and Julie Cherrington, San Francisco, Calif. (US) |
Assigned to Sugen, Inc, South San Francisco, Calif. (US); and Pharmacia Corporation, St. Louis, Mo. (US) |
Filed on Aug. 15, 2002, as Appl. No. 10/218,910. |
Claims priority of provisional application 60/312413, filed on Aug. 15, 2001. |
Prior Publication US 2003/0216410 A1, Nov. 20, 2003 |
Int. Cl. A61K 31/40 (2006.01); A61K 31/415 (2006.01)
|